In 35 years, Audevard has become the only pharmaceutical laboratory exclusively dedicated to horses in Europe, giving a unique position within the equine industry. More than half of Audevard’s sales is made with licensed medicines and the rest comes from a scientific nutraceutical range, which can be combined with the medicines in various protocols for comprehensive management of the horse's health.
In the recent years, Audevard has also succeeded in its international development by achieving more than 50% of its sales outside of its home market France, mainly in the major European equine countries. Since 2021, Audevard has been part of the LIM Group, a French corporation consisting of companies exclusively dedicated to the equine sector via a “RIDING” and a “HEALTH” division.